Sylvan Baca is an Assistant Professor of Medicine at Harvard Medical School, a medical oncologist at the Dana-Farber Cancer Institute, and an Associate Member of the Broad Institute. Raised in Albuquerque, NM, Dr. Baca received his undergraduate degree from Stanford University and his MD and PhD from Harvard Medical School. He trained in Internal Medicine at Brigham and Women’s Hospital and completed his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. Dr. Baca received his post-doctoral training in cancer epigenetics with Dr. Matthew Freedman at the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT. He is on faculty at the Dana-Farber Cancer Institute as a Physician and Investigator. In addition to caring for patients, he conducts research at the interface of computational biology and epigenomics to find better ways to treat cancer.